# Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients

> **NCT01109134** · PHASE3 · COMPLETED · sponsor: **Kosuyolu Heart Hospital** · enrollment: 49 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** tirofiban intracoronary bolus-only
- **DRUG:** tirofiban intravenous bolus plus infusion

## Key facts

- **NCT ID:** NCT01109134
- **Lead sponsor:** Kosuyolu Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-02
- **Final completion:** 2009-08
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2010-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109134, "Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01109134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*